Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Merger discussions between NextCell and Idogen are suspended
May 9, 2019

The discussions of a potential merger between biotechnology companies NextCell Pharma AB and Idogen AB have been suspended due to deal structural disagreements. The two companies both develop cell therapy solutions, which also was the logic behind entering merger discussions.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: